BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang WB, Yang Y, Zhao YP, Zhang TP, Liao Q, Shu H. Recent studies of 5-fluorouracil resistance in pancreatic cancer. World J Gastroenterol 2014; 20(42): 15682-15690 [PMID: 25400452 DOI: 10.3748/wjg.v20.i42.15682]
URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15682.htm
Number Citing Articles
1
Giordano Perini, Enrico Rosa, Ginevra Friggeri, Lorena Di Pietro, Marta Barba, Ornella Parolini, Gabriele Ciasca, Chiara Moriconi, Massimiliano Papi, Marco De Spirito, Valentina Palmieri. INSIDIA 2.0 High-Throughput Analysis of 3D Cancer Models: Multiparametric Quantification of Graphene Quantum Dots Photothermal Therapy for Glioblastoma and Pancreatic CancerInternational Journal of Molecular Sciences 2022; 23(6): 3217 doi: 10.3390/ijms23063217
2
Yumeng Wei, Panjing Yang, Shousong Cao, Ling Zhao. The combination of curcumin and 5-fluorouracil in cancer therapyArchives of Pharmacal Research 2018; 41(1): 1 doi: 10.1007/s12272-017-0979-x
3
Myrna Hurtado, Laszlo Prokai, Umesh T. Sankpal, Blair Levesque, Rajasekhar Maram, Jaya Chhabra, Deondra T. Brown, Raj K. Gurung, Alvin A. Holder, Jamboor K. Vishwanatha, Riyaz Basha. Next generation sequencing and functional pathway analysis to understand the mechanism of action of copper-tolfenamic acid against pancreatic cancer cellsProcess Biochemistry 2020; 89: 155 doi: 10.1016/j.procbio.2019.10.022
4
Siriwan Sakarin, Nuntana Meesiripan, Suleeporn Sangrajrang, Nuntakan Suwanpidokkul, Piyaporn Prayakprom, Chatchada Bodhibukkana, Vipada Khaowroongrueng, Kankanit Suriyachan, Somchai Thanasittichai, Attasit Srisubat, Pattamaporn Surawongsin, Kasem Rattanapinyopituk. Antitumor Effects of Cannabinoids in Human Pancreatic Ductal Adenocarcinoma Cell Line (Capan-2)-Derived Xenograft Mouse ModelFrontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.867575
5
Shamin Azwar, Heng Fong Seow, Maha Abdullah, Mohd Faisal Jabar, Norhafizah Mohtarrudin. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer TreatmentBiology 2021; 10(9): 854 doi: 10.3390/biology10090854
6
Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A reviewBiomedicine & Pharmacotherapy 2020; 131: 110768 doi: 10.1016/j.biopha.2020.110768
7
Dhanya Moorkoth, Kesavan Madhavan Nampoothiri, Selvaraj Nagarajan, Aswathy Ravindran Girija, Sivakumar Balasubramaniyan, D. Sakthi Kumar. Star-Shaped Polylactide Dipyridamole Conjugated to 5-Fluorouracil and 4-Piperidinopiperidine Nanocarriers for Bioimaging and Dual Drug Delivery in Cancer CellsACS Applied Polymer Materials 2021; 3(2): 737 doi: 10.1021/acsapm.0c01043
8
Jebraeel Movaffagh, Hamide Salari, Elahe Merajifar, Hamid Gholamhosseinian, Azadeh Shahroodi, Mehrdad Iranshahi, FatemehB Rassouli. 7-geranyloxycoumarin enhanced radiotherapy effects on human gastric adenocarcinoma cellsJournal of Cancer Research and Therapeutics 2021; 0(0): 0 doi: 10.4103/jcrt.jcrt_701_21
9
Matthew B. Lipner, Xianlu L. Peng, Chong Jin, Yi Xu, Yanzhe Gao, Michael P. East, Naim U. Rashid, Richard A. Moffitt, Silvia G. Herrera Loeza, Ashley B. Morrison, Brian T. Golitz, Cyrus Vaziri, Lee M. Graves, Gary L. Johnson, Jen Jen Yeh. Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapyJCI Insight 2020; 5(8) doi: 10.1172/jci.insight.129905
10
Klaudia Siwowska, Raffaella Schmid, Susan Cohrs, Roger Schibli, Cristina Müller. Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo CharacterizationPharmaceuticals 2017; 10(4): 72 doi: 10.3390/ph10030072
11
Lukas M. Braun, Simon Lagies, Jessica Guenzle, Stefan Fichtner-Feigl, Uwe A. Wittel, Bernd Kammerer. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell LinesCells 2020; 9(5): 1251 doi: 10.3390/cells9051251
12
Nkafu Bechem Ndemazie, Andriana Inkoom, Dexter Ebesoh, Raviteja Bulusu, Esther Frimpong, Jose Trevino, Bo Han, Xue Zhu, Edward Agyare. Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancerBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10449-y
13
Thangirala Sudha, Kavitha Godugu, Gennadi V. Glinsky, Shaker A. Mousa. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic CancerBiomedicines 2022; 10(4): 795 doi: 10.3390/biomedicines10040795
14
Lucas D. Lee, Ioannis Pozios, Verena Liu, Silke B. Nachbichler, Dirk Böhmer, Carsten Kamphues, Katharina Beyer, Christiane J. Bruns, Martin E. Kreis, Hendrik Seeliger. Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinomaRadiation and Environmental Biophysics 2022; 61(2): 255 doi: 10.1007/s00411-022-00962-w
15
Zhaorong Chen, Aling Shen, Liya Liu, Youqin Chen, Jianfeng Chu, Qiaoyan Cai, Fei Qi, Thomas Joseph Sferra, Jun Peng. Pien Tze Huang induces apoptosis and inhibits proliferation of 5-fluorouracil-resistant colorectal carcinoma cells via increasing miR-22 expressionExperimental and Therapeutic Medicine 2017; 14(4): 3533 doi: 10.3892/etm.2017.4951
16
Sanaz Naghizadeh, Behzad Mansoori, Ali Mohammadi, Ebrahim Sakhinia , Behzad Baradaran. Gene Silencing Strategies in Cancer Therapy: An Update for Drug ResistanceCurrent Medicinal Chemistry 2019; 26(34): 6282 doi: 10.2174/0929867325666180403141554
17
Patricia Santofimia-Castaño, Juan Iovanna. Combating pancreatic cancer chemoresistance by triggering multiple cell death pathwaysPancreatology 2021; 21(3): 522 doi: 10.1016/j.pan.2021.01.010
18
Girijesh Kumar Patel, Mohammad Aslam Khan, Arun Bhardwaj, Sanjeev K Srivastava, Haseeb Zubair, Mary C Patton, Seema Singh, Moh'd Khushman, Ajay P Singh. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCKBritish Journal of Cancer 2017; 116(5): 609 doi: 10.1038/bjc.2017.18
19
Eun-Kyung Kim, MinGyeong Jang, Min-Jeong Song, Dongwoo Kim, Yosup Kim, Ho Hee Jang. Redox-Mediated Mechanism of Chemoresistance in Cancer CellsAntioxidants 2019; 8(10): 471 doi: 10.3390/antiox8100471
20
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolismCritical Reviews in Oncology/Hematology 2017; 114: 139 doi: 10.1016/j.critrevonc.2017.03.026
21
Elisa Majounie, Kathleen Wee, Laura M. Williamson, Martin R. Jones, Erin Pleasance, Howard J. Lim, Cheryl Ho, Daniel J. Renouf, Stephen Yip, Steven J.M. Jones, Marco A. Marra, Janessa Laskin. Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variantMolecular Case Studies 2020; 6(1): a004713 doi: 10.1101/mcs.a004713
22
Huaichuan Duan, Kaixuan Hu, Dan Zheng, Yan Cheng, Zelan Zhang, Yueteng Wang, Li Liang, Jianping Hu, Ting Luo. Recognition and release of uridine and hCNT3: From multivariate interactions to molecular designInternational Journal of Biological Macromolecules 2022; 223: 1562 doi: 10.1016/j.ijbiomac.2022.11.145
23
Imlimaong Aier, Rahul Semwal, Aiindrila Dhara, Nirmalya Sen, Pritish Kumar Varadwaj, James Freeman. An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinomaPLOS ONE 2019; 14(10): e0223554 doi: 10.1371/journal.pone.0223554
24
Ali Alsuraifi, Paul Lin, Anthony Curtis, Dimitrios Lamprou, Clare Hoskins. A Novel PAA Derivative with Enhanced Drug Efficacy in Pancreatic Cancer Cell LinesPharmaceuticals 2018; 11(4): 91 doi: 10.3390/ph11040091
25
Vadim V. Tarasov, Vladimir N. Chubarev, Ghulam Md Ashraf, Samira A. Dostdar, Alexander V. Sokolov, Tatiana I. Melnikova, Susanna S. Sologova, Ekaterina M. Grigorevskich, Alfiya Makhmutovа, Alexander S. Kinzirsky, Sergey G. Klochkov, Gjumrakch Aliev. How Cancer Cells Resist Chemotherapy: Design and Development of Drugs Targeting Protein-Protein InteractionsCurrent Topics in Medicinal Chemistry 2019; 19(6): 394 doi: 10.2174/1568026619666190305130141
26
Mounira Chalabi-Dchar, Tanguy Fenouil, Christelle Machon, Anne Vincent, Frédéric Catez, Virginie Marcel, Hichem C Mertani, Jean-Christophe Saurin, Philippe Bouvet, Jérôme Guitton, Nicole Dalla Venezia, Jean-Jacques Diaz. A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fateNAR Cancer 2021; 3(3) doi: 10.1093/narcan/zcab032
27
Btissame El Hassouni, Giovanna Li Petri, Daniel S.K. Liu, Stella Cascioferro, Barbara Parrino, Waqar Hassan, Patrizia Diana, Asif Ali, Adam E Frampton, Elisa Giovannetti. Pharmacogenetics of treatments for pancreatic cancerExpert Opinion on Drug Metabolism & Toxicology 2019; 15(6): 437 doi: 10.1080/17425255.2019.1620731
28
Nestor Prieto-Dominguez, Austin Y Shull, Yong Teng. Making way for suppressing the FGF19/FGFR4 axis in cancerFuture Medicinal Chemistry 2018; 10(20): 2457 doi: 10.4155/fmc-2018-0099
29
Adriana Harbuzariu, Ruben Rene Gonzalez-Perez. Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancerOncotarget 2018; 9(26): 18239 doi: 10.18632/oncotarget.24435
30
Takashi Hoshiba, Masaru Tanaka. Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2016; 1863(11): 2749 doi: 10.1016/j.bbamcr.2016.08.009
31
Chiara Caparello, Laura L Meijer, Ingrid Garajova, Alfredo Falcone, Tessa Y Le Large, Niccola Funel, Geert Kazemier, Godefridus J Peters, Enrico Vasile, Elisa Giovannetti. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancerWorld Journal of Gastroenterology 2016; 22(31): 6987-7005 doi: 10.3748/wjg.v22.i31.6987
32
Oscar Briz, Laura Perez-Silva, Ruba Al-Abdulla, Lorena Abete, Maria Reviejo, Marta R. Romero, Jose J.G. Marin. What “The Cancer Genome Atlas” database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugsExpert Opinion on Drug Metabolism & Toxicology 2019; 15(7): 577 doi: 10.1080/17425255.2019.1631285
33
Ding Wang, Dan Yu, Xueshibojie Liu, Qian Wang, Xuyang Chen, Xindan Hu, Qiong Wang, Chunshun Jin, Lianji Wen, Ling Zhang. Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticlesTechnology in Cancer Research & Treatment 2020; 19: 153303382096211 doi: 10.1177/1533033820962114
34
Abdullah A. Ghawanmeh, Kwok Feng Chong, Shaheen M. Sarkar, Muntaz Abu Bakar, Rizafizah Othaman, Rozida M. Khalid. Colchicine prodrugs and codrugs: Chemistry and bioactivitiesEuropean Journal of Medicinal Chemistry 2018; 144: 229 doi: 10.1016/j.ejmech.2017.12.029
35
Suresh Chava, Meher B. Gayatri, Aramati B.M. Reddy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy2019; : 25 doi: 10.1016/B978-0-12-817661-0.00003-2
36
Niklas Sturm, Thomas J. Ettrich, Lukas Perkhofer. The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and TherapyCancers 2022; 14(1): 217 doi: 10.3390/cancers14010217
37
Jose Marin, Candela Cives-Losada, Maitane Asensio, Elisa Lozano, Oscar Briz, Rocio Macias. Mechanisms of Anticancer Drug Resistance in HepatoblastomaCancers 2019; 11(3): 407 doi: 10.3390/cancers11030407
38
Angelika Długosz-Pokorska, Joanna Drogosz, Marlena Pięta, Tomasz Janecki, Urszula Krajewska, Marek Mirowski, Anna Janecka. New Uracil Analogs with Exocyclic Methylidene Group as Potential Anticancer AgentsAnti-Cancer Agents in Medicinal Chemistry 2020; 20(3): 359 doi: 10.2174/1871520619666191211104128
39
Masaaki Murakawa, Toru Aoyama, Yohei Miyagi, Yosuke Atsumi, Keisuke Kazama, Koichiro Yamaoku, Amane Kanazawa, Manabu Shiozawa, Satoshi Kobayashi, Makoto Ueno, Manabu Morimoto, Naoto Yamamoto, Takashi Oshima, Takaki Yoshikawa, Yasushi Rino, Munetaka Masuda, Soichiro Morinaga. Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapyOncology Letters 2017; 14(2): 1505 doi: 10.3892/ol.2017.6295
40
Welley S. Loc, Samuel S. Linton, Zachary R. Wilczynski, Gail L. Matters, Christopher O. McGovern, Thomas Abraham, Todd Fox, Christopher M. Gigliotti, Xiaomeng Tang, Amra Tabakovic, Jo Ann Martin, Gary A. Clawson, Jill P. Smith, Peter J. Butler, Mark Kester, James H. Adair. Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancerNanomedicine: Nanotechnology, Biology and Medicine 2017; 13(7): 2313 doi: 10.1016/j.nano.2017.06.017
41
Wnt-11 Expression Promotes Invasiveness and Correlates with Survival in Human Pancreatic Ductal Adeno CarcinomaGenes 2019; 10(11): 921 doi: 10.3390/genes10110921
42
Yibo Fu, Francesca Ricciardiello, Gang Yang, Jiangdong Qiu, Hua Huang, Jianchun Xiao, Zhe Cao, Fangyu Zhao, Yueze Liu, Wenhao Luo, Guangyu Chen, Lei You, Ferdinando Chiaradonna, Lianfang Zheng, Taiping Zhang. The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer CellsCells 2021; 10(3): 497 doi: 10.3390/cells10030497
43
Sugata Barui, Nicolò Maria Percivalle, Marzia Conte, Bianca Dumontel, Luisa Racca, Marco Carofiglio, Valentina Cauda. Development of doped ZnO-based biomimicking and tumor-targeted nanotheranostics to improve pancreatic cancer treatmentCancer Nanotechnology 2022; 13(1) doi: 10.1186/s12645-022-00140-z
44
Chinmayee Sethy, Chanakya Nath Kundu. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibitionBiomedicine & Pharmacotherapy 2021; 137: 111285 doi: 10.1016/j.biopha.2021.111285
45
Myrna Hurtado, Umesh T. Sankpal, Amalendu Ranjan, Rajasekhar Maram, Jamboor K. Vishwanatha, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes, Riyaz Basha. Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancerCritical Reviews in Oncology/Hematology 2018; 126: 201 doi: 10.1016/j.critrevonc.2018.03.016
46
Yitian Chen, Liangping Su, Cheng Huang, Sangqing Wu, Xiaoyi Qiu, Xinbao Zhao, Qiong Meng, Ya-Ming Meng, Xiangzhan Kong, Minghui Wang, Chao Liu, Ping-Pui Wong. Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110Cancer Letters 2021; 500: 228 doi: 10.1016/j.canlet.2020.12.006
47
Mi-Ju Kim, Min-Sun Kim, Sung Joo Kim, Soyeon An, Jin Park, Hosub Park, Jae Hoon Lee, Ki-Byung Song, Dae Wook Hwang, Suhwan Chang, Kyu-pyo Kim, Seong-Yun Jeong, Song Cheol Kim, Seung-Mo Hong. Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patientsCancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0416-8
48
Isabel Mejia, Sandhya Bodapati, Kathryn T. Chen, Begoña Díaz. Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical TrialsBiomedicines 2020; 8(10): 401 doi: 10.3390/biomedicines8100401
49
Marzia Conte, Valentina Cauda. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine TreatmentsAdvanced Therapeutics 2022; 5(11): 2200079 doi: 10.1002/adtp.202200079
50
Yoonseon Jeong, Joo Lim, Hyeyoung Kim. Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer CellsNutrients 2019; 11(4): 762 doi: 10.3390/nu11040762
51
JUNRO KATAOKA, HIDENORI SHIRAHA, SHIGERU HORIGUCHI, HIROAKI SAWAHARA, DAISUKE UCHIDA, TERUYA NAGAHARA, MASAYA IWAMURO, HIROKI MORIMOTO, YASUTO TAKEUCHI, KENJI KUWAKI, HIDEKI ONISHI, SHINICHIRO NAKAMURA, AKINOBU TAKAKI, KAZUHIRO NOUSO, TAKAHITO YAGI, KAZUHIDE YAMAMOTO, HIROYUKI OKADA. Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinomaOncology Reports 2016; 35(5): 2576 doi: 10.3892/or.2016.4681
52
Samaneh Pasban, Heidar Raissi, Majid Pakdel, Farzaneh Farzad. Enhance the efficiency of 5-fluorouracil targeted delivery by using a prodrug approach as a novel strategy for prolonged circulation time and improved permeationInternational Journal of Pharmaceutics 2019; 568: 118491 doi: 10.1016/j.ijpharm.2019.118491
53
Woonghee Lee, Gwonhwa Song, Hyocheol Bae. Laminarin Attenuates ROS-Mediated Cell Migration and Invasiveness through Mitochondrial Dysfunction in Pancreatic Cancer CellsAntioxidants 2022; 11(9): 1714 doi: 10.3390/antiox11091714
54
Lihong Shen, Junping Hu, Haixian Wang, Aibing Wang, Yisheng Lai, Yanhui Kang. Synthesis and biological evaluation of novel uracil and 5-fluorouracil-1-yl acetic acid-colchicine conjugateChemical Research in Chinese Universities 2015; 31(3): 367 doi: 10.1007/s40242-015-4445-3
55
Saffiyeh Saboor-Maleki, Fatemeh B. Rassouli, Maryam M. Matin, Mehrdad Iranshahi. Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer CellsTechnology in Cancer Research & Treatment 2017; 16(4): 519 doi: 10.1177/1533034616650119
56
Alexey Dementiev, Andrzej Joachimiak, Ha Nguyen, Alexei Gorelik, Katalin Illes, Saman Shabani, Michael Gelsomino, Eun-Young Erin Ahn, Bhushan Nagar, Ninh Doan. Molecular Mechanism of Inhibition of Acid Ceramidase by CarmofurJournal of Medicinal Chemistry 2019; 62(2): 987 doi: 10.1021/acs.jmedchem.8b01723
57
Wenyue Liu, Jingwei Zhang, Xuequan Yao, Chao Jiang, Ping Ni, Lingge Cheng, Jiali Liu, Suiying Ni, Qianying Chen, Qingran Li, Kai Zhou, Guangji Wang, Fang Zhou. Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathwayCancer Science 2018; 109(10): 3294 doi: 10.1111/cas.13779
58
Yoshihiko Tasaki, Miho Suzuki, Keisuke Katsushima, Keiko Shinjo, Kenta Iijima, Yoshiteru Murofushi, Aya Naiki-Ito, Kazuki Hayashi, Chenjie Qiu, Akiko Takahashi, Yoko Tanaka, Tokuichi Kawaguchi, Minoru Sugawara, Tomoya Kataoka, Mitsuru Naito, Kanjiro Miyata, Kazunori Kataoka, Tetsuo Noda, Wentao Gao, Hiromi Kataoka, Satoru Takahashi, Kazunori Kimura, Yutaka Kondo. Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic CancerCancer Research 2021; 81(7): 1654 doi: 10.1158/0008-5472.CAN-20-3021